New NHS guidance is set to revolutionise the care for thousands of women in the UK living with Premature Ovarian Insufficiency (PMOS), a condition that affects approximately one in 100 women under the age of 40. The annual health checks, which are now recommended for these women, aim to provide a proactive and holistic approach to managing their long-term health, helping to mitigate the risks associated with PMOS and improve quality of life.
PMOS, sometimes referred to as premature menopause, occurs when a woman's ovaries stop functioning normally before the age of 40. This leads to reduced oestrogen levels, which can have significant implications for various bodily systems. The new annual checks will focus on key areas such as cardiovascular health, bone density, and mental wellbeing – all of which can be adversely affected by lower oestrogen levels over time.
The risks associated with PMOS are substantial: reduced oestrogen levels increase the risk of developing osteoporosis, a condition that weakens bones and makes them more susceptible to fractures. Furthermore, there is an elevated risk of cardiovascular disease, including heart attacks and strokes. The new guidance provides a framework for healthcare professionals to systematically monitor these risks, potentially leading to earlier interventions and better health outcomes.
Currently, the approach to managing PMOS can vary across different NHS trusts and GP practices. This new, standardised guidance seeks to ensure that all women with the condition receive consistent and comprehensive care. The annual health checks are intended to complement existing treatments, such as hormone replacement therapy (HRT), by providing a regular opportunity to assess overall health and adjust treatment plans as necessary.
The implementation of these annual checks will require coordination across primary and secondary care services within the NHS. GPs will play a central role in conducting these reviews, referring patients to specialists where necessary. This integrated approach aims to reduce the burden on individual patients to seek out fragmented care and instead provide a clear, annual pathway for health management.
The new guidance is welcomed by patient advocacy groups, who have long campaigned for improved support and recognition for women with PMOS. The long-term goal is to reduce health inequalities and improve the life expectancy and wellbeing of women living with PMOS across the UK.